Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §112 only | 1 (17%) |
| No statute on record | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 1 | 42.8% | +67.6% |
| POHNERT, STEVEN C | 1 | 12.1% | +18.3% |
| REGLAS, GILLIAN CHELSEA | 1 | 27.5% | +55.9% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.7% |
| PRONZATI, GINA | 1 | 66.7% | +41.7% |
| MCLEOD, AFRICA MHAIRIE | 1 | 44.7% | +68.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19034863 | AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR | POHNERT, STEVEN C | 8d |
| 18806641 | USE OF ADENO-ASSOCIATED VIRAL VECTORS TO CORRECT GENE DEFECTS/ EXPRESS PROTEINS IN HAIR CELLS AND SUPPORTING CELLS IN THE INNER EAR | REGLAS, GILLIAN CHELSEA | 54d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18314671 | CELL SPECIFIC GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS | PRONZATI, GINA | 32d overdue |
| 19034863 | AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR | POHNERT, STEVEN C | 8d |
| 17998486 | COMPOSITIONS AND METHODS FOR TREATING GJB2-ASSOCIATED HEARING LOSS | MCLEOD, AFRICA MHAIRIE | 9d |
| 18314661 | CELL SPECIFIC GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS | CHONG, KIMBERLY | 13d |
| 19095986 | ANTI-VEGF ANTIBODY CONSTRUCTS AND RELATED METHODS FOR TREATING VESTIBULAR SCHWANNOMA ASSOCIATED SYMPTOMS | SINGH, ANOOP KUMAR | 28d |
| 18806641 | USE OF ADENO-ASSOCIATED VIRAL VECTORS TO CORRECT GENE DEFECTS/ EXPRESS PROTEINS IN HAIR CELLS AND SUPPORTING CELLS IN THE INNER EAR | REGLAS, GILLIAN CHELSEA | 54d |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| 1683 | 1 |
| 1636 | 1 |
| 1633 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19095986 | ANTI-VEGF ANTIBODY CONSTRUCTS AND RELATED METHODS FOR TREATING VESTIBULAR SCHWANNOMA ASSOCIATED SYMPTOMS | SINGH, ANOOP KUMAR | 1632 | §112 | Non-Final OA | 28d | Pending | Mar 31, 2025 |
| 19034863 | AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR | POHNERT, STEVEN C | 1683 | §103 | Non-Final OA | 8d | Pending | Jan 23, 2025 |
| 18806641 | USE OF ADENO-ASSOCIATED VIRAL VECTORS TO CORRECT GENE DEFECTS/ EXPRESS PROTEINS IN HAIR CELLS AND SUPPORTING CELLS IN THE INNER EAR | REGLAS, GILLIAN CHELSEA | 1632 | §103 | Final Rejection | 54d | Pending | Aug 15, 2024 |
| 18314661 | CELL SPECIFIC GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS | CHONG, KIMBERLY | 1636 | Other | Non-Final OA | 13d | Pending | May 09, 2023 |
| 18314671 | CELL SPECIFIC GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS | PRONZATI, GINA | 1633 | Other | Non-Final OA | 32d overdue | Pending | May 09, 2023 |
| 17998486 | COMPOSITIONS AND METHODS FOR TREATING GJB2-ASSOCIATED HEARING LOSS | MCLEOD, AFRICA MHAIRIE | 1635 | Other | Non-Final OA | 9d | Pending | Nov 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial